Mechanisms of protein SUMOylation and its functional consequences
This project aims to elucidate the structure and mechanism of SUMO E3 ligases and investigate the consequences of SUMOylation on protein complexes to enhance understanding of SUMO-regulated pathways.
Projectdetails
Introduction
Protein post-translational modification with small ubiquitin-like modifiers (SUMO1, -2, and -3), also known as SUMOylation, targets a third of human proteins, is essential for organisms from yeast to humans, and has strong links to cancer and neurodegeneration.
SUMOylation and E3 Ligases
Like ubiquitylation, to which it is related, SUMOylation typically depends on the action of enzymes called E3 ligases, which help determine substrate specificity and the exact signal that is produced.
However, while for ubiquitylation several hundred E3s are known, no more than two dozen SUMO-specific E3s have been described and only four characterized structurally in a way that reveals their mechanism.
Intriguingly, the SUMO E3 ligase activity keeps being detected in proteins that are unrelated to each other and sometimes can be mapped to apparent disordered regions.
Project Objectives
In the first part of this project, I will explore the poorly charted territory of SUMO writing by elucidating the structure and mechanism of some known SUMO E3 ligases for which the mechanism is unclear.
This analysis will serve as a stepping stone to proposing computational, chemical biology, and structural biology approaches to identifying and characterizing new SUMO E3s.
Investigating SUMOylation Consequences
In the second part, I will investigate downstream consequences of SUMOylation. Following attachment to a protein substrate, SUMOylation is thought to function as a molecular glue by promoting the formation of protein complexes with specific SUMO readers, but detailed structural and biochemical information is lacking for any of such putative assemblies.
To address this topic, I will develop strategies to identify and characterize SUMO-dependent complexes.
Broader Implications
The new tools, approaches, and knowledge about SUMO writing and reading will be broadly applicable to pathways regulated by SUMOylation, allowing their understanding in molecular and mechanistic terms.
The study will also explore general concepts in protein evolution and the evolutionary emergence of signaling systems.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.493.515 |
Totale projectbegroting | € 1.493.515 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 31-12-2027 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
(Re-)Writing the Ubiquitin Code – Manipulating Polyubiquitin Chain Linkage to Investigate Ubiquitin Signalling in Genome Maintenance and BeyondThis project aims to develop innovative tools for studying polyubiquitylation's role in genome maintenance and its implications for cancer and aging, enhancing our understanding of cellular signaling pathways. | ERC Advanced... | € 2.499.799 | 2025 | Details |
Deciphering the regulatory logic of the ubiquitin systemThis project aims to elucidate the substrate recognition mechanisms of E3 ubiquitin ligases using functional genetic approaches to enhance understanding of the ubiquitin-proteasome system for therapeutic applications. | ERC Starting... | € 1.528.843 | 2025 | Details |
Ubiquitin-Proteasome System crosstalk with MetabolismThis project aims to elucidate the regulatory crosstalk between ubiquitination and cellular metabolites using advanced biophysical techniques to enhance understanding of metabolic homeostasis. | ERC Advanced... | € 2.089.688 | 2023 | Details |
ADPribosylation and Ubiquitination; post-translational interplayThis project aims to investigate the interplay between ubiquitination and ADPribosylation in cellular processes to develop novel therapeutic strategies for diseases like infections and cancer. | ERC Consolid... | € 1.999.625 | 2024 | Details |
The origin and impact of impaired ubiquitin signaling in the degeneration of neuronsThis project aims to investigate dysregulated ubiquitin signaling as an early cause of neurodegeneration, using innovative human neuronal models to enhance understanding and treatment of Alzheimer's disease. | ERC Advanced... | € 2.500.000 | 2024 | Details |
(Re-)Writing the Ubiquitin Code – Manipulating Polyubiquitin Chain Linkage to Investigate Ubiquitin Signalling in Genome Maintenance and Beyond
This project aims to develop innovative tools for studying polyubiquitylation's role in genome maintenance and its implications for cancer and aging, enhancing our understanding of cellular signaling pathways.
Deciphering the regulatory logic of the ubiquitin system
This project aims to elucidate the substrate recognition mechanisms of E3 ubiquitin ligases using functional genetic approaches to enhance understanding of the ubiquitin-proteasome system for therapeutic applications.
Ubiquitin-Proteasome System crosstalk with Metabolism
This project aims to elucidate the regulatory crosstalk between ubiquitination and cellular metabolites using advanced biophysical techniques to enhance understanding of metabolic homeostasis.
ADPribosylation and Ubiquitination; post-translational interplay
This project aims to investigate the interplay between ubiquitination and ADPribosylation in cellular processes to develop novel therapeutic strategies for diseases like infections and cancer.
The origin and impact of impaired ubiquitin signaling in the degeneration of neurons
This project aims to investigate dysregulated ubiquitin signaling as an early cause of neurodegeneration, using innovative human neuronal models to enhance understanding and treatment of Alzheimer's disease.